文献速递认知障碍与痴呆

遗传推断的非洲祖先比例与痴呆血液生物标志物纵向变化的关联

Associations of Longitudinal Changes in Blood Biomarkers of Dementia With the Proportion of Genetically Inferred African Ancestry.
PubMed 文献 · Neurology · 2025-08-08

研究利用家族与社区健康研究(FCHS)的纵向数据,在573名(横断面)和225名(纵向)非洲裔美国人中分析遗传推断的非洲祖先比例与血清p-Tau181、GFAP、NfL纵向变化的关系。发现非洲祖先比例与横断面生物标志物水平无关,但与p-Tau181的纵向变化呈负相关(β=-14.50 pg/mL, p=0.02)。欧洲队列中与ADRD相关的遗传因素在本队列中与三种生物标志物无关。

要点

  • 非洲祖先比例越高,11年间血清p-Tau181升高幅度越小(β=-14.50 pg/mL, p=0.02)。
  • 非洲祖先比例与横断面p-Tau181、GFAP、NfL水平均无显著关联。
  • 欧洲队列中鉴定的ADRD相关遗传因素在非洲裔美国人队列中与三种生物标志物无关。

核心结论

  • 有提示性证据表明,较高的非洲祖先比例与血清p-Tau181随时间增加的衰减相关。

研究设计与样本

  • 研究使用1996年启动的家族与社区健康研究(FCHS)纵向数据,招募并随访了889个居住在佐治亚州和爱荷华州的非洲裔美国家庭。
  • 血清p-Tau181、GFAP和NfL在2008年(第5波)和2019年(第8波)采集的样本中测定。
  • 横断面样本包括573名参与者(平均年龄55.1岁,69%女性),纵向样本包括225名(平均年龄57.2岁,80%女性)。

主要发现

  • 非洲祖先比例与横断面生物标志物水平无关。
  • 非洲祖先比例与p-Tau181的纵向变化呈负相关(β=-14.50 pg/mL, p=0.02),该关联在调整年龄、性别、APOE ε4、社会经济状况、体力活动、吸烟、主观认知下降及多种心血管危险因素和合并症后仍稳健。
  • 欧洲队列中与AD和生物标志物相关的遗传因素在本非洲裔美国人队列中与三种生物标志物无关。

关键数值与推荐

  • 非洲祖先比例与p-Tau181纵向变化的关联:β=-14.50 pg/mL, p=0.02。
  • 排除遗传推断为三级亲属或更近的密切亲属个体。
  • 遗传祖先比例使用ADMIXTURE分析推断。

临床怎么用

  • 对于非洲裔美国人,遗传祖先比例可能影响血液p-Tau181的纵向动态,解读系列p-Tau181变化时应考虑祖先背景。
  • 欧洲队列中鉴定的ADRD相关遗传因素可能不完全适用于非洲裔美国人,需谨慎外推遗传风险信息。

局限性

  • 纵向样本量较小(225人),结果需更大样本验证。
  • 研究仅提示关联,不能确定因果或驱动生物学/社会文化因素。
  • 生物标志物仅测两次(2008年和2019年),纵向变化动态刻画有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: African American individuals have a higher risk of Alzheimer disease (AD) and related dementia (ADRD) than non-Hispanic White individuals. Some cross-sectional studies with self-reported race and ethnicity have reported racial differences in circulating ADRD biomarkers, including phosphorylated tau181 (p-Tau181), glial fibrillary acidic protein (GFAP), and neurofilament light (NfL). We aimed to examine the associations of genetically inferred African ancestry proportion with the longitudinal changes in these biomarkers and to evaluate the associations of previously identified ADRD-related genetic factors in European cohorts with these biomarkers in an African American cohort. METHODS: This study used longitudinal data from the Family and Community Health Study, which was initiated in 1996, recruited and followed 889 African American families residing in Georgia and Iowa. Circulating p-Tau181, GFAP, and NfL were measured in serum samples collected in 2008 (wave 5) and 2019 (wave 8). Closely related individuals, genetically inferred to be third-degree relatives or closer, were excluded. Genetic ancestry proportions were inferred using the ADMIXTURE analysis. Multivariable regression analyses were performed to test the associations of African ancestry proportion with cross-sectional biomarker levels and their longitudinal changes over 11 years. We also tested the associations of selected genetic variants, polygenic scores, and APOE ε4 status with these biomarkers. RESULTS: Our cross-sectional sample included 573 participants (mean age = 55.1 years; 69% female), whereas our longitudinal sample included 225 (57.2 years; 80% female). African ancestry proportion was not associated with cross-sectional biomarker levels but was inversely associated with the longitudinal change in p-Tau181 (β = -14.50 pg/mL, p = 0.02). The significant inverse association was robust to adjustment for age, sex, APOE ε4, socioeconomic status, physical activity, smoking, subjective cognitive decline, and various cardiovascular risk factors and comorbidities. Finally, genetic factors associated with AD and biomarkers in European cohorts were not associated with the 3 biomarkers in our African American cohort. DISCUSSION: We found suggestive evidence that a higher African ancestry proportion is associated with an attenuated increase in the blood p-Tau181 level over time. More research is needed to characterize the longitudinal dynamics of ADRD biomarkers across ancestry and the driving biological or sociocultural factors.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Wang L, Xu H, Simons RL, et al. Associations of Longitudinal Changes in Blood Biomarkers of Dementia With the Proportion of Genetically Inferred African Ancestry. Neurology. 2025. PMID: 40779734. doi:10.1212/WNL.0000000000213976

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。